Efficacy and Safety of Molnupiravir for the Treatment of Non-Hospitalized Adults With Mild COVID-19: A Randomized, Open-Label, Parallel-Group Phase 3 Trial
Tippabhotla et al., SSRN Electronic Journal, doi:10.2139/ssrn.4042673
https://c19early.org/tippabhotla.html